Classical Hematology Faculty Position

The Dan L. Duncan Comprehensive Cancer Center (DLDCCC) and the Department of Medicine at Baylor College of Medicine (BCM) in Houston, Texas, are recruiting a full-time classical (non-malignant/benign) hematologist with strong interest and expertise in the management of hematological disorders and translational/clinical research to join our growing Section of Hematology/Oncology at the Assistant/Associate/Professor level. The successful candidate will conduct clinic and attend on the hematology consult service, teaching at Baylor St. Luke’s Medical Center (BSLMC). A multitude of opportunities as well as protected time is available for engaging in translational and/or clinical research. The DLDCCC is an NCI-designated comprehensive cancer center affiliated with BSLMC, Ben Taub Hospital, the Michael E DeBakey VA Medical Center, and Texas Children’s Hospital. At BSLMC, benign hematology is a rapidly expanding pillar of our program, with distinctive clinical and academic opportunities. Many of our hematology faculty are currently supported by NIH and foundation-level grants driving research that advances the understanding of blood-clotting disorders and how these conditions are managed across health systems. Interested candidates may participate in and help shape our growing CTEPH program, the Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence, and engage in multidisciplinary care for rare disorders including vascular anomalies, thrombotic microangiopathies, and bone marrow failure syndromes. Our partnerships with Texas Children’s Hospital and the Pavilion for Women offer exceptional avenues for collaborative research and co-management in pediatric-to-adult hematology transitions, women’s health benign hematology, and complex disorders such as thrombophilia and other pregnancy associated hematologic conditions. In addition, there are robust opportunities to lead or participate in benign hematology clinical trials, fully supported by the DLDCCC Clinical Trials Support Unit (CTSU). This includes access to experienced research coordinators, regulatory specialists, and infrastructure that facilitates the activation and successful conduct of investigator-initiated and industry sponsored studies. Faculty benefit from the strong collaborative culture of the DLDCCC, which encompasses six well-funded basic science research programs and ten disease-focused working groups designed to bring basic scientists and clinicians together to accelerate translational discovery in hematology and related fields. Interested candidates must have an M.D or M.D./Ph.D. degree and be board-certified in Internal Medicine and board-certified or board-eligible in Hematology and eligible for a medical license in Texas.

About the Employer

The Baylor College of Medicine (BCM) is a private medical school in Houston, Texas. The college consists of four schools: the School of Medicine, the Graduate School of Biomedical Sciences, the School of Health Professions, and the National School of Tropical Medicine.

The school is part owner, alongside Catholic Health Initiatives (CHI), of Baylor St. Luke's Medical Center, the flagship hospital of the CHI St. Luke's Health system. Other affiliated teaching hospitals and research institutes include Harris Health System's Ben Taub Hospital, Texas Children's Hospital, The University of Texas MD Anderson Caner Center, TIRR, Memorial Hermann, the Menninger Clinic, and the Michael E. Debakey VA Medical Center.

How to Apply

Interested candidates should submit the below items to Dr. Leo Luznik at HemeOncRecruitment@bcm.edu: Applications should include a letter outlining the candidate’s academic interests, a curriculum vitae, and the names of four references. Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.

Contact Information

Christina Rodriguez
One Baylor Plaza
Houston, TX 77030 USA
https://www.bcm.edu/
hemeoncrecruitment@bcm.edu